在墨西哥患有青少年异常性关节炎的儿童中,SLCO1B1多态和甲状腺素不耐受之间的关系
Jimena Garcia-Silva1, Beatriz Silva-Ramirez2, Ana V Villarreal-Treviño1
1Departamento de Pediatría, Hospital Universitario "José Eleuterio González", Universidad Autónoma de Nuevo León, Av. Francisco I. Madero Pte. y Av. Gonzalitos, Col. Mitras Centro C.P., 64460, Monterrey, NL, Mexico.
Clinical rheumatology
|November 3, 2024
概括
SLCO1B1基因的遗传变异与青少年异常性关节炎中甲状腺素不良事件有关. *1B单元型增加了副作用的风险,这表明需要优化剂量.
科学领域:
- 药物基因组学 药物基因组学
- 免疫学 免疫学 免疫学
- 儿科风湿病学 儿科风湿病学
背景情况:
- 甲托雷克萨特 (MTX) 的不良事件 (AE),包括胃肠道问题和肝毒性,往往会降低青少年异常性关节炎 (JIA) 的治疗坚持和有效性.
- SLCO1B1基因编码肝脏输送物OATP1B1,影响药物的药理动力学. 在SLCO1B1中的遗传变异可以改变MTX运输,清除和毒性风险.
研究的目的:
- 调查SLCO1B1基因 (rs4149056,rs2306283) 中单核酸多态 (SNPs) 与接受MTX治疗的JIA儿科患者中AEs发生率之间的联系.
主要方法:
- 进行了一项观察性回顾性研究.
- 分析了小儿JIA患者中SLCO1B1基因SNP和MTX相关的AE之间的关系.
主要成果:
- 包括30名JIA患者 (平均年龄为11岁,73.3%为女性);66.7%的患者经历过AEs.
- *1B亚型是普遍存在的 (53.3%) 和显著与增加的风险的AE (OR=3.89,p=0.03) 相关.
结论:
- 患有*1B等位基因的患者可能需要减少MTX剂量.
- 通过SLCO1B1基因定型,可以识别患有MTXAE风险较高的JIA患者,从而实现个性化剂量优化.
相关概念视频
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
143
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
143
Translation
14.6K
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Proteins are...
Translation Produces the Building Blocks of Life
Proteins are...
14.6K
Lethal Alleles
15.0K
Agouti: A Lethal Allele
Lucien Cuénot discovered lethal alleles in 1905 while studying the inheritance of coat color in mice. The agouti gene is responsible for the color of the coat in mice. This gene codes for an agouti-signaling protein, which is responsible for melanin distribution in mammals. The wild-type allele gives rise to gray-brown coat color in mice, while the mutant allele gives rise to yellow coat color. In addition to coat color, the agouti gene is associated with the yellow...
Lucien Cuénot discovered lethal alleles in 1905 while studying the inheritance of coat color in mice. The agouti gene is responsible for the color of the coat in mice. This gene codes for an agouti-signaling protein, which is responsible for melanin distribution in mammals. The wild-type allele gives rise to gray-brown coat color in mice, while the mutant allele gives rise to yellow coat color. In addition to coat color, the agouti gene is associated with the yellow...
15.0K
Drugs for Treatment of Ulcerative Colitis in IBD
124
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
124
Non-LTR Retrotransposons
11.4K
As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...
11.4K
Phase II Reactions: Methylation Reactions
143
Methylation is a phase II biotransformation process involving the attachment of a methyl group to a substrate. Enzymes known as methyltransferases orchestrate this reaction.
The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled...
The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled...
143


